Robin Joan Steele
Director · Dare Bioscience, Inc.
Individual
- 2025
- Jul 2, 2026
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Robin Joan Steele's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Sanj K. Patel - $39.43M in KNSA purchases and sales in the last 12 months
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $2.65B in MDLN purchases and sales in the last 12 months
- BX Mozart ML-2 Holdco L.P. - $2.35B in MDLN purchases and sales in the last 12 months
- BCP 8 Holdings Mozart Manager L.L.C. - $2.35B in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robin Joan Steele?
Robin Joan Steele is a corporate insider, tracked as Director of Dare Bioscience, Inc. (DARE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Robin Joan Steele last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 3 filings going back to 2025.
